Please try another search
For the six months ended 30 June 2017, Protea Biosciences Group Inc revenues decreased 35% to $683K. Net loss increased from $2.9M to $11.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Gains from sales of investment decrease of 93% to $85K (income), Interest expense increase from $524K to $1.7M (expense).
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Revenue | 0.33 | 0.35 | 0.87 | 0.52 |
Gross Profit | -0.06 | 0.07 | 0.33 | 0.05 |
Operating Income | -1.37 | -1.56 | -1.12 | -1.49 |
Net Income | -5.5 | -5.86 | -7.24 | -5.52 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Assets | 2.83 | 2.65 | 3.21 | 3.33 |
Total Liabilities | 14.63 | 19.08 | 17.32 | 19.24 |
Total Equity | -11.81 | -16.42 | -14.11 | -15.91 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -2.27 | -0.83 | -4.23 | -3.41 |
Cash From Investing Activities | 0.02 | -0.02 | 1.48 | 1.48 |
Cash From Financing Activities | 2.26 | 0.79 | 2.82 | 1.92 |
Net Change in Cash | 0 | -0.06 | 0.07 | -0.01 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review